Devicam Capital LLP's Insider Trades & SAST Disclosures
Devicam Capital LLP's most recent trade in Solara Active Pharma Sciences Ltd. was a Disposal of 2,013,747 Equity Shares done at an average price of Rs. 339.7 . Disclosure was reported to the exchange on Dec. 27, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Devicam Capital LLP's has made SAST transactions in Sequent Scientific Ltd. recently where a Pledge of 2,955,000 shares done . Disclosure was reported to the exchange on Aug. 17, 2020.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sequent Scientific | Devicam Capital LLP | Promoter | Pledge | 24 Dec 2024 | 2,955,000 | 0 | - | - | 17 Aug 2020 17 Aug 2020 |
SAST (Reg31) | - | Release | |
| Solara Active Pharma | Devicam Capital LLP & Others | Promoter | Acquisition | 04 Jul 2024 | 6,915,516 | 17,889,320 (37.27%) | 6.79% | - | 19 Jun 2024 19 Jun 2024 |
SAST (29(2)) | - | Rights Issue | |
| Solara Active Pharma | Devicam Capital LLP & Others | Promoter | Disposal | 09 Jan 2024 | 2,013,747 | 1,039,298 (2.89%) | 5.59% | - | 26 Dec 2023 26 Dec 2023 |
SAST (29(2)) | - | Market | |
| Solara Active Pharma | Devicam Capital LLP & Others | Promoter | Acquisition | 09 Jan 2024 | 2,013,747 | 3,758,500 (10.44%) | 5.59% | - | 26 Dec 2023 26 Dec 2023 |
SAST (29(1)) | - | Market | |
| Solara Active Pharma | Devicam Capital LLP | Promoter Group | Disposal | 27 Dec 2023 | 2,013,747 | 1,039,298 (2.89%) | 5.59% | 339.7 | 683,970,578 | 26 Dec 2023 26 Dec 2023 |
Insider Trading | Equity Shares | Off Market |
| Solara Active Pharma | Devicam Capital LLP | Other | Acquisition | 20 Dec 2022 | 1,400,000 | - | 3.89% | - | 09 Dec 2022 09 Dec 2022 |
SAST (10(6)) | - | - | |
| Solara Active Pharma | Karuna Business Solutions LLP & Devicam Capital LLP | Promoter | Disposal | 13 Dec 2022 | 1,400,000 | 1,441,370 (4%) | 3.89% | - | 09 Dec 2022 09 Dec 2022 |
SAST (29(2)) | - | Inter-se Transfer | |
| Solara Active Pharma | Devicam Capital LLP & Karuna Business Solutions LLP | Promoter | Acquisition | 13 Dec 2022 | 1,400,000 | 3,053,045 (8.48%) | 3.89% | - | 09 Dec 2022 09 Dec 2022 |
SAST (29(2)) | - | Inter-se Transfer | |
| Solara Active Pharma | Devicam Capital LLP | Promoter Group | Acquisition | 13 Dec 2022 | 1,400,000 | 3,053,045 (8.48%) | 3.89% | 470.3 | 658,350,000 | 09 Dec 2022 09 Dec 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Solara Active Pharma | Devicam Capital LLP | Promoter | Acquisition | 06 Dec 2022 | 700,000 | - | 1.94% | - | 07 Dec 2022 07 Dec 2022 |
SAST (10(1)(a)) | - | None | |
| Solara Active Pharma | Devicam Capital LLP | Promoter | Acquisition | 06 Dec 2022 | 1,400,000 | - | 3.89% | - | 07 Dec 2022 07 Dec 2022 |
SAST (10(1)(a)) | - | None | |
| Solara Active Pharma | Devicam Capital LLP | Promoter Group | Acquisition | 16 Aug 2022 | 583 | 1,653,045 (4.59%) | 0.00% | 360.8 | 210,343 | 11 Aug 2022 11 Aug 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Solara Active Pharma | Devicam Capital LLP | Promoter Group | Acquisition | 16 Aug 2022 | 916 | 1,652,462 (4.59%) | 0.00% | 360.8 | 330,488 | 10 Aug 2022 10 Aug 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Solara Active Pharma | Devicam Capital LLP | Other | Acquisition | 30 Jun 2022 | 1,500,000 | - | 4.17% | - | 22 Jun 2022 01 Jan 1900 |
SAST (10(6)) | - | - | |
| Solara Active Pharma | Devicam Capital LLP & Arun Kumar Pillai | Promoter | Acquisition | 29 Jun 2022 | 1,500,000 | 1,651,546 (4.59%) | 4.17% | - | 22 Jun 2022 22 Jun 2022 |
SAST (29(2)) | - | Inter-se Transfer | |
| Solara Active Pharma | Devicam Capital LLP | Promoter Group | Acquisition | 27 Jun 2022 | 1,500,000 | 1,651,546 (4.59%) | 4.17% | 408.9 | 613,350,000 | 22 Jun 2022 22 Jun 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Solara Active Pharma | Devicam Capital LLP | Promoter | Acquisition | 02 Jun 2022 | 1,500,000 | - | 4.17% | - | 08 Jun 2022 08 Jun 2022 |
SAST (10(1)(a)) | - | None | |
| Sequent Scientific | Devicam Capital LLP | Promoter | Disposal | 22 Aug 2020 | 3,788,670 | 0 (0%) | 1.53% | 86 | 325,825,620 | 17 Aug 2020 17 Aug 2020 |
Insider Trading | Equity Shares | Off Market |
| Sequent Scientific | Devicam Capital LLP & PACs | Promoter | Disposal | 20 Aug 2020 | 62,595,375 | 76,877,262 (30.95%) | 25.20% | - | 17 Aug 2020 17 Aug 2020 |
SAST (29(2)) | - | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.